Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 11.55B | 13.17B | 13.26B | 15.56B | 13.77B |
Gross Profit | 5.08B | 6.56B | 6.76B | 8.71B | 6.16B |
EBITDA | -504.00M | 1.18B | -142.00M | 2.33B | -170.00M |
Net Income | -1.01B | 585.00M | -740.00M | 1.02B | -1.33B |
Balance Sheet | |||||
Total Assets | 19.26B | 21.39B | 20.48B | 22.14B | 20.36B |
Cash, Cash Equivalents and Short-Term Investments | 8.31B | 12.70B | 11.24B | 13.25B | 11.11B |
Total Debt | 13.00M | 26.00M | 60.00M | 110.00M | 176.00M |
Total Liabilities | 2.40B | 3.08B | 2.68B | 3.33B | 2.41B |
Stockholders Equity | 16.85B | 18.32B | 17.81B | 18.81B | 17.95B |
Cash Flow | |||||
Free Cash Flow | -3.14B | 1.10B | -1.37B | 2.44B | -1.46B |
Operating Cash Flow | -1.80B | 1.51B | -733.00M | 3.00B | -1.04B |
Investing Cash Flow | -2.68B | 117.00M | -1.08B | -639.00M | 3.32B |
Financing Cash Flow | -509.00M | -160.00M | -193.00M | -225.00M | -219.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥6.68B | 7.91 | 3.07% | -9.85% | -8.43% | ||
79 Outperform | ¥8.94B | 6.15 | 2.46% | 1.86% | -13.39% | ||
76 Outperform | ¥8.12B | 54.02 | 3.04% | -4.37% | -54.08% | ||
72 Outperform | ¥5.20B | 8.80 | 1.85% | 5.65% | 67.65% | ||
67 Neutral | ¥252.71B | 13.20 | 6.45% | 2.71% | 5.22% | -11.89% | |
66 Neutral | ¥5.95B | 345.48 | ― | 219.88% | 73.21% | ||
47 Neutral | ¥6.00B | ― | 2.11% | -12.30% | -274.85% |